← Back to Search

MedReviewRx for Overmedication

N/A

Waitlist Available

Led By Emily McDonald, MD

Research Sponsored by Centre for Innovation and Research in Aging, Canada

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

No Placebo-Only Group

Summary

This trial tests MedReviewRx, an app that helps doctors and pharmacists review and simplify medications for older adults in New Brunswick nursing homes. The goal is to reduce unnecessary or harmful medications, making treatment safer and potentially lowering costs. The app analyzes medications and health conditions, providing reports to guide safer prescribing.

Eligible Conditions

Overmedication
Deprescribing
Adverse Drug Reactions

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Impact of MedReviewRx on the prevalence of potentially inappropriate medications (PIMs) in New Brunswick nursing homes (NBNHs).

Secondary study objectives

Change in functional status based on interRAI activities of daily living (ADL) scores.

Number of changes from baseline in composite safety data

Number of deaths

+10 more

Other study objectives

Cost savings

Patient and family attitudes about deprescribing

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: MedReviewRxExperimental Treatment1 Intervention

During the intervention phase, MedReviewRx will be made available to nursing homes with the understanding that it will be used to facilitate medication reviews and prescription check-ups. MedReviewRx provides clinicians with access to individualized and prioritized deprescribing information from MedSafer which: a) identifies potentially inappropriate medications (PIMs), b) explains why the medication is potentially inappropriate and c) provides instructions on how to safely stop/taper the medication.

Group II: No MedReviewRxActive Control1 Intervention

During the control phase, MedReviewRx will not be accessible to health care professionals at the nursing homes. This serves to obtain baseline deprescribing levels for each nursing home.

Do I qualify?Apply below to find out